The Breaking through emergent immunotherapy and immune targets in cancer workshop brings together academic leaders to discuss the latest advances and opportunities in immuno-oncology, including combination immunotherapy strategies, emerging immuno-oncology targets and next-generation immunotherapies, oncolytic viruses, personalized neoantigen-targeted therapies, and adoptive t-cell therapy. The attendees will discover the latest developments in the immuno-oncology field.